News | September 23, 2023
Lupin acquires five brands from Menarini
Lupin has been exclusively marketing these brands in the Indian market since July 2021
Lupin has been exclusively marketing these brands in the Indian market since July 2021
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Subscribe To Our Newsletter & Stay Updated
